Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 10,370
-140 (-1.33%)
At close: Apr 3, 2026
Penetrium Bioscience Market Cap
Penetrium Bioscience has a market cap or net worth of 575.56 billion as of April 2, 2026. Its market cap has increased by 649.49% in one year.
Market Cap
575.56B
Enterprise Value
578.81B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,370.00
Market Cap Chart
Since June 3, 2021, Penetrium Bioscience's market cap has increased from 215.74B to 575.56B, an increase of 166.78%. That is a compound annual growth rate of 22.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 575.56B | 341.60% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | 215.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 114.16B |
| HLB bioStep | 100.60B |
| P&K Skin Research Center | 57.65B |
| C&R Research | 44.37B |
| DT&CRO CO. | 42.89B |
| WOOJUNG BIO | 41.23B |
| SLS BIO | 26.89B |
| BioInfra | 19.14B |